Amgen Sees Significant Institutional Investment Amid Quarter Results
Ausdal Financial Partners Inc., an institutional investor, acquired a new stake in Amgen Inc. (NASDAQ:AMGN) during the second quarter of this year.
The company reported acquiring 2,893 shares of the medical research company's stock, valued at approximately $1,048,000, according to its recent filing with the Securities & Exchange Commission.
This is not an isolated instance of institutional investment in Amgen. Other investors have also bought and sold shares of the company.